Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,411 | -16,947 | -8,388 | -39,479 | -30,315 |
| Depreciation Amortization | -625 | -527 | -308 | -1,633 | -1,266 |
| Accounts payable and accrued liabilities | 50 | 755 | 314 | -1,769 | -784 |
| Other Working Capital | 1,123 | 1,404 | -135 | 1,274 | 405 |
| Other Operating Activity | 4,650 | 2,055 | 1,079 | 9,443 | 6,215 |
| Operating Cash Flow | $-20,213 | $-13,260 | $-7,438 | $-32,164 | $-25,745 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,682 | 13,032 | 7,224 | 651 | 2,459 |
| Investing Cash Flow | $26,682 | $13,032 | $7,224 | $651 | $2,459 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 1,224 | 1,224 |
| Common Stock Repurchased | -87 | -87 | -87 | -156 | -155 |
| Financing Cash Flow | $-87 | $-87 | $-87 | $1,068 | $1,069 |
| Beginning Cash Position | 6,697 | 6,697 | 6,697 | 37,142 | 37,142 |
| End Cash Position | 13,079 | 6,382 | 6,396 | 6,697 | 14,925 |
| Net Cash Flow | $6,382 | $-315 | $-301 | $-30,445 | $-22,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,213 | -13,260 | -7,438 | -32,164 | -25,745 |
| Free Cash Flow | -20,213 | -13,260 | -7,438 | -32,164 | -25,745 |